At the point when I see the blue and green plastic jars coating the roads of my area, filled to their edges with squander, I generally feel inquisitive about the destiny of the substance inside. Those minutes where your brain is overflowed with inquiries concerning the ordinary regular sights and you contemplate internally “what is life?” what does everything mean?” and “where does everything go?”

The uplifting news is, our recyclables do head off to some place, and we are living in an inconceivable time for what happens to recyclables once they show up at your city’s neighborhood community. Despite the fact that it wasn’t until the 1970s that reusing truly became standard, reusing programs grabbed hold in towns and urban areas during the beginning of the green development and “multi-material curbside assortment programs” began getting set up.

Today, the framework for both gathering and handling our recyclables has progressively gotten more smoothed out as headway in innovation and hardware has created. While the idea may appear to be overwhelming, the entire cycle can be separated into 3 primary advances:

1. Recyclables are gathered.

Each city and local area is a little extraordinary in how reusing is gathered however most urban areas have obligatory reusing laws that require reusing assortment and focus activity. Unquestionably investigate your city’s reusing rules and guidelines to know your territory’s reusing rules about recycling. Urban areas likewise have various guidelines for what you can and can’t reuse. It’s critical to comprehend which holders that can’t be reused or that can taint a reusing cluster on account of left over food buildup.

• Here are a few instances of things that commonly can’t be reused:
• Extremely oily pizza boxes—if the container isn’t oily it very well may be reused, or you can simply reuse the side of the crate that isn’t oily.
• Single-use paper cups, in light of the fact that most are fixed with a film of polyethylene (you can reuse the plastic cover independently).
• Plastics named with the numbers 3, 6, and 7 (however some named #7 are compostable).
• Plastic sacks ought not be placed into your reusing container (there are a few habitats in urban communities that will take your plastic packs, however they actually should be isolated).

2. Recyclables are brought to a middle and arranged.

Once at the middle, the receptacles are poured onto enormous machines and with the assistance of laborers, the substances are arranged by type, for example papers, plastics, jars and so forth Laborers likewise help to isolate clean recyclables from dirtied ones into various heaps.

There is consistently disarray around whether you should wash your recyclables and a life affirming guideline is “the cleaner the better,” in light of the fact that producers will pay more for the cleaner holders. Most offices won’t discard a holder, however, and most have frameworks set up for cleaning them—yet again try to peruse your city’s rules.

3. Purchasers buy the reused products.

Recyclables are really viewed as an item. After the recyclables are arranged, producers will come to reusing focuses to purchase the arranged reused products. They at that point take them to be prepared, separate them into crude materials and make them into new items. The most sought-after plastics that makers search for are plastics marked with a 1, 2, 4, or 5. Prior to purchasing plastic compartments like a spread tub, take a gander at the number that it is named with prior to buying.

Purchasers have assumed an enormous part in this cycle due to the ascent of mindfulness around reused bundling. Along these lines, the worth that a maker will pay for reused products has expanded throughout the long term. Makers purchasing from the reusing focuses is likewise what pays to keep the reusing focus running.

There is additionally energizing innovation starting to build up that can cycle materials that can’t be reused and end up in landfills. The organization PureCycle Technologies is right now constructing an innovation that takes materials made with polypropylene and other material that can’t be reused (like texture) and melts it down to make a virgin gum taking into account a more extensive method of reusing waste.

Everything we can manage as purchasers is expected to discard as little as could be expected, following a zero-squander way of life. Begin to execute little propensities like bringing your own holders for food, drinks, and to-go food. You can likewise be aware of the kinds of plastics you are buying by getting mindful of the numbers marked on the compartments. When reusing, put forth a valiant effort to clean your recyclables however much as could be expected while being aware of water utilization, and set aside some effort to find out about your city’s reusing rules.

Instructions

Critically analyze each of the identified organizational challenges you identified in Week 3 and compare them with Capella University’s criteria for an approvable doctoral capstone topic and project and with elements needed for the application of EBP improvement. Then, make a case for focusing on one challenge as the best opportunity for EBP improvement in a potential doctoral capstone project.

Requirements

The assignment requirements, outlined below, correspond to the scoring guide criteria, so be sure to address each main point. Read the performance-level descriptions for each criterion to see how your work will be assessed. In addition, note the additional requirements for document format, length, and supporting evidence.

• Describe the characteristics of a professional doctorate and doctoral capstone project.
  • Compare professional activities and roles for individuals with a DHA or DrPH degree compared to a PhD degree.
  • Delineate the differences and similarities between a DHA or DrPH capstone project and a PhD dissertation.
  • Describe three major characteristics of a doctoral capstone project.
• Critically analyze the potential of evidence-based improvement to mitigate the negative impact of each of the three identified organizational challenges.
  • Describe the appropriateness of applying the EBP process to mitigate the negative impact of the identified challenges.
  • Summarize the quality of available research evidence to support a potential project focused on mitigating the negative impact of the identified challenges.
  • Describe how the EBP process could facilitate improvements that mitigate the negative impact of the challenges in a short period of time.
• Determine the extent to which a project focused on mitigating the negative impact of each of the three organizational challenges meets Capella University criteria for a doctoral capstone project.
  • Outline what a doctoral capstone project is and what it is not, according to Capella University criteria for a doctoral capstone project.
  • Describe how the application of existing knowledge to mitigate the negative impact of the challenges aligns with your program and specialization and contributes to your field.
  • Summarize Capella University criteria that would be met by a doctoral capstone project focused on mitigating the negative impact of the challenges.
• Argue for the potential success and approval of a doctoral capstone project focused on the evidence-based improvement of one challenge the organization is facing.
  • Describe how the evidence-based improvement of one challenge meets professional doctorate, EBP, and university standards and criteria.
• Write concisely and directly, using active voice.
• Apply APA style and formatting to scholarly writing.

Additional Requirements

• Format: Format your paper using APA style. Use the APA Style Paper Template [DOCX]. An APA Style Paper Tutorial [DOCX] is also provided to help you in writing and formatting your paper. Be sure to include:
  • A title page and reference page. An abstract is not required.
  • A running head on all pages.
  • Appropriate section headings.
• Length: Your paper should be 3–4 pages in length, not including the title page and reference page.
• Supporting evidence: Cite at least two current and relevant peer-reviewed studies. Provide in-text citations and references in APA format.iscussion:

  1. Access and affordability: This is simultaneously an environment where we have made exceptional strides in turning cancer into a chronic disease and adding years to life. At the same time, we still struggle with access and affordability. On the affordability front, the cost of the therapies including the drugs and immunotherapy has implications for access. With such a prevalent and horrible disease as cancer, ideally you would want treatment to be 100% accessible. We need a healthcare system that is dramatically improved in quality, dramatically improved in access, and dramatically improved in affordability and sustainability for patients, doctors, employers, and the country. Quality, access, and cost are major challenges that are going to require transformative change. With access, one in four Americans will defer care because of cost reasons. One in three Americans will not take prescription drugs because of cost. One of the major causes of personal bankruptcy is healthcare. We have a highly inefficient system. Out of the $3.5 trillion that we spend on healthcare in this country, which is close to 19% of our gross domestic product, about $700 billion to $900 billion is wasteful care.

  2. Geographic barriers: In our case, we get a lot of patients who come from all over the country and all over the world. We get many patients who come to us after they have tried treatment at their local hospital. It’s a major journey for these patients to travel. By offering telehealth and partnering with local providers, we are trying to bridge this gap. But just because you have wonderful new therapies and protocols at facilities like ours, it doesn’t mean that everyone can overcome the geographical barriers to access them.

  3. Time: There might be a clinical trial that is in its infancy but it’s so close to unlocking an important scientific discovery that I would wish that I could get it to patients today instead of a year from now. Time is also a factor in catching disease early and preventing disease. Just like with cardiac care and diabetes, there are lots of things that can prevent cancer, up to 50% of cancer is preventable. Through prevention and very early detection and diagnosis, we can stop cancers at the cellular level before they progress to more complex diseases. Often, the treatment side gets the most attention, more dollars, and more resources. Treatment is very important, but we need to pay as much attention to devoting dollars and resources to prevention and diagnosis.

  References

  National Cancer Policy Forum; Board on Health Care Services; Institute of Medicine. Delivering Affordable Cancer Care in the 21st Century: Workshop Summary. Washington (DC): National Academies Press (US); 2013 May 20. CURRENT CHALLENGES. Available from: https://www.ncbi.nlm.nih.gov/books/NBK202475/

  van de Haar J, Hoes LR, Coles CE, et al: Caring for patients with cancer in the COVID-19 era. Nat Med 26:665-671, 2020 [Erratum: Nat Med 26:1146, 2020]

   

   

   

  Discussion Response:

  Nicely summarized post.  I agree with you that the cost of drugs and/or treatment within the United States has become unreasonable and is resulting in patients having to make decisions between food on their table or medicine for their disease.  Rajkumar (2020) found that global spending on prescription drugs averaged $1.3 trillion in 2020, with the United States making up $350 billion of the total.  Globally, spending on prescription drugs is expected to increase 3%-6% year on year.  Hunter (2011) reported that the average price of a life-saving oncology drug can cost $100,000-$150,000 annually in the US.

  Reducing the price of prescription drugs has no easy solution, especially in markets like the United States where there are no government controlled price caps or value-based pricing requirements.  Fundamental changes to global and United States (US) policies are necessary if drug prices are lowered, but careful consideration must be taken to appropriately compensate pharmaceutical companies for the costs associated with research and development.  It is an extremely delicate balance that requires transparency and input from all key stakeholders.

  References

  Hunter, J.  (2011).  Challenges for pharmaceutical industry: new partnerships for sustainable human health.  The Royal Society, 369, 1942.  https://doi.org/10.1098/rsta.2010.0377.

  Rajkumar, S. V.  (2020).  The high cost of prescription drugs: causes and solutions [Editorial].  Blood Cancer Journal, 10(71).  https://doi.org/10.1038/s41408-020-0338-x.